Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q2 2022 call → NOWe need to determine if the transcript describes a situation where a proven instance is being replicated now, with demand already identified at the destination, and this replication is large relative to the company. Let's examine the transcript for such a pattern. The question asks about "copying a part of its own business that is already working into additional places where the same demand is already visible." This could be about geographic expansion, product replication, etc. Key candidates: - The S&P Dow Jones Indices JV investment: They invested $410 million to fund acquisition of IHS Markit Indices business, keeping ownership at 27%. This is an investment, not necessarily replicating a proven unit. It's expanding the JV's product scope. Not exactly copying a proven instance. - The SOFR transition: They are moving from Eurodollar to SOFR futures and options. They have fee waivers to incentivize adoption. They are seeing growth in SOFR. But is this a replication? They are transitioning products, not necessarily standing up additional instances of a proven unit. They are trying to get RPCs (revenue per contract) to match Eurodollar levels. Not a physical replication. - The Google partnership and cloud migration: They are building foundational services. Not a replication of a proven unit. - The launch of new products like Micro Copper, options on Micro WTI, etc. These are new product launches, not necessarily replicating a proven unit in multiple locations. - The event contracts: They are planning to launch event contracts later this year. That's a new product, not yet proven. - The international growth: They are seeing growth in non-US volumes. But is that a replication of a proven unit? They are expanding internationally, but they already have international operations. They are not standing up new instances of a specific proven unit.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.